rs3743079
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004136.4(IREB2):c.*576C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.151 in 152,480 control chromosomes in the GnomAD database, including 1,784 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.15 ( 1779 hom., cov: 33)
Exomes 𝑓: 0.14 ( 5 hom. )
Consequence
IREB2
NM_004136.4 3_prime_UTR
NM_004136.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.612
Publications
20 publications found
Genes affected
IREB2 (HGNC:6115): (iron responsive element binding protein 2) The protein encoded by this gene is an RNA-binding protein that acts to regulate iron levels in the cells by regulating the translation and stability of mRNAs that affect iron homeostasis under conditions when iron is depleted. When iron levels are low, this protein binds to iron-responsive elements (IRES), stem-loop structures located either in the 5' or 3' UTRs. Binding to the 5' UTR represses translation, while binding to the 3' UTR inhibits mRNA degradation. When iron is found in the cell, this protein is degraded in a F-box and leucine rich repeat protein 5-dependent manner. Variants in this gene have been associated with lung cancer and chronic obstructive pulmonary disease (COPD). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2017]
IREB2 Gene-Disease associations (from GenCC):
- neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemiaInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.158 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IREB2 | NM_004136.4 | c.*576C>T | 3_prime_UTR_variant | Exon 22 of 22 | ENST00000258886.13 | NP_004127.2 | ||
| IREB2 | NM_001320942.2 | c.*576C>T | 3_prime_UTR_variant | Exon 22 of 22 | NP_001307871.2 | |||
| IREB2 | NM_001354994.2 | c.*576C>T | 3_prime_UTR_variant | Exon 22 of 22 | NP_001341923.2 | |||
| IREB2 | NM_001320941.2 | c.*576C>T | 3_prime_UTR_variant | Exon 21 of 21 | NP_001307870.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IREB2 | ENST00000258886.13 | c.*576C>T | 3_prime_UTR_variant | Exon 22 of 22 | 1 | NM_004136.4 | ENSP00000258886.8 |
Frequencies
GnomAD3 genomes AF: 0.151 AC: 23003AN: 152060Hom.: 1772 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
23003
AN:
152060
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.136 AC: 41AN: 302Hom.: 5 Cov.: 0 AF XY: 0.149 AC XY: 29AN XY: 194 show subpopulations
GnomAD4 exome
AF:
AC:
41
AN:
302
Hom.:
Cov.:
0
AF XY:
AC XY:
29
AN XY:
194
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
AC:
0
AN:
4
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
0
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
24
AN:
222
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
16
AN:
70
Other (OTH)
AF:
AC:
1
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.540
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.151 AC: 23039AN: 152178Hom.: 1779 Cov.: 33 AF XY: 0.151 AC XY: 11251AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
23039
AN:
152178
Hom.:
Cov.:
33
AF XY:
AC XY:
11251
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
5909
AN:
41520
American (AMR)
AF:
AC:
1686
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
710
AN:
3472
East Asian (EAS)
AF:
AC:
766
AN:
5178
South Asian (SAS)
AF:
AC:
774
AN:
4822
European-Finnish (FIN)
AF:
AC:
1731
AN:
10578
Middle Eastern (MID)
AF:
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10937
AN:
68004
Other (OTH)
AF:
AC:
348
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1004
2007
3011
4014
5018
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
264
528
792
1056
1320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
580
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.